Literature DB >> 11317355

Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.

R Bargal1, N Avidan, T Olender, E Ben Asher, M Zeigler, A Raas-Rothschild, A Frumkin, O Ben-Yoseph, Y Friedlender, D Lancet, G Bach.   

Abstract

The gene MCOLN1 is mutated in Mucolipidosis type IV (MLIV), a neurodegenerative, recessive, lysosomal storage disorder. The disease is found in relatively high frequency among Ashkenazi Jews due to two founder mutations that comprise 95% of the MLIV alleles in this population [Bargal et al., 2000]. In this report we complete the mutation analysis of Jewish and non-Jewish MLIV patients whose DNA were available to us. Four novel mutations were identified in the MCOLN1 gene of severely affected patients: two missense, T232P and F465L; a nonsense, R322X; and an 11-bp insertion in exon 12. The nonsense mutation (R322X) was identified in two unrelated patients with different haplotypes in the MCOLN1 chromosomal region, indicating a mutation hotspot in this CpG site. An in-frame deletion (F408del) was identified in a patient with unusual mild psychomotor retardation. The frequency of MLIV in the general Jewish Ashkenazi population was estimated in a sample of 2,000 anonymous, unrelated individuals assayed for the two founder mutations. This analysis indicated a heterozygotes frequency of about 1/100. A preferred nucleotide numbering system for MCOLN1 mutations is presented and the issue of a screening program for the detection of high-risk families in the Jewish Ashkenazi population is discussed. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317355     DOI: 10.1002/humu.1115

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  32 in total

1.  Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.

Authors:  Lisa Edelmann; Jianli Dong; Robert J Desnick; Ruth Kornreich
Journal:  Am J Hum Genet       Date:  2002-02-13       Impact factor: 11.025

2.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

3.  Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene.

Authors:  Sylvia L Anderson; Josef Ekstein; Mary C Donnelly; Erin M Keefe; Nicole R Toto; Lauretta A LeVoci; Berish Y Rubin
Journal:  Hum Genet       Date:  2004-06-23       Impact factor: 4.132

4.  Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy.

Authors:  David A Zeevi; Shaya Lev; Ayala Frumkin; Baruch Minke; Gideon Bach
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

5.  Lysosomal localization of TRPML3 depends on TRPML2 and the mucolipidosis-associated protein TRPML1.

Authors:  Kartik Venkatachalam; Thomas Hofmann; Craig Montell
Journal:  J Biol Chem       Date:  2006-04-10       Impact factor: 5.157

6.  Comprehensive arrayed primer extension array for the detection of 59 sequence variants in 15 conditions prevalent among the (Ashkenazi) Jewish population.

Authors:  Iris Schrijver; Maigi Külm; Phyllis I Gardner; Eugene P Pergament; Morris B Fiddler
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

Review 7.  Lysosomal physiology.

Authors:  Haoxing Xu; Dejian Ren
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 8.  TRPMLs: in sickness and in health.

Authors:  Rosa Puertollano; Kirill Kiselyov
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

Review 9.  Invertebrate TRP proteins as functional models for mammalian channels.

Authors:  Joris Vriens; Grzegorz Owsianik; Thomas Voets; Guy Droogmans; Bernd Nilius
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

Review 10.  Mucolipin 1: endocytosis and cation channel--a review.

Authors:  Gideon Bach
Journal:  Pflugers Arch       Date:  2004-11-27       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.